Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links

Andrea Jazel Rodríguez-Herrera1, Sabrina Setembre Batah1, Maria Júlia Faci do Marco1

  • 1Department of Pathology and Forensic Medicine, Ribeirão Preto Medical School (FMRP), University of São Paulo (USP), Ribeirão Preto 14049-900, SP, Brazil.

PubMed
Abstract

Insights

Pulmonary fungal infections can cause pulmonary hypertension through vascular remodeling. Early recognition and research are vital for managing this under-recognized complication in immunocompromised patients.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Cardiology

Background:

  • Pulmonary fungal infections pose diagnostic challenges, particularly in immunocompromised individuals.
  • Untreated infections can lead to significant morbidity, mortality, and chronic inflammation.
  • This chronic inflammation can result in vascular remodeling and pulmonary hypertension.

Purpose of the Study:

  • To review the mechanisms of vascular remodeling in pulmonary hypertension secondary to fungal infections.
  • To highlight the under-recognized clinical and research gap regarding this condition.

Main Methods:

  • This is a narrative mini-review.
  • It synthesizes information on inflammatory and immune responses to fungal infections.
  • It focuses on mechanisms leading to vascular remodeling and pulmonary hypertension.

Main Results:

  • Fungal infections trigger inflammatory responses that promote myofibroblast recruitment and extracellular matrix deposition.
  • Vascular remodeling occurs through endothelial injury, direct inflammation-driven remodeling, and distant remodeling in granulomatous diseases.
  • Pulmonary hypertension is a significant but under-recognized consequence.

Conclusions:

  • Three primary mechanisms contribute to vascular remodeling: endothelial injury, chronic infection-driven remodeling, and post-infection remodeling.
  • Increased clinical awareness and research are needed for pulmonary hypertension in fungal infections.
  • Screening for pulmonary hypertension in affected patients is recommended to improve outcomes.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
291
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
571
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
371